Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026)
Dentsply Sirona's (XRAY) quarterly Cash from Financing Activities came in at -$119.0 million in Q1 2026, down 196.75% YoY from $123.0 million in Q1 2025, and down 20.2% on a QoQ basis from -$99.0 million in Q4 2025.
Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Dentsply Sirona (XRAY) has 18 years of Cash from Financing Activities data on file, last reported at -$119.0 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 196.75% year-over-year to -$119.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$322.0 million (down 95.15% YoY) and the FY2025 annual result came in at -$80.0 million, up 73.51% from the prior year.
- Cash from Financing Activities declined to -$119.0 million in Q1 2026, from -$99.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $123.0 million in Q1 2025 to a low of -$171.0 million in Q2 2024.
- A 5-year average of -$66.9 million and a median of -$79.0 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 1716.67% — and 2025, when it jumped 978.57%.
- Tracing XRAY's Cash from Financing Activities over 5 years: stood at -$161.0 million in 2022, then rose by 20.5% to -$128.0 million in 2023, then soared by 70.31% to -$38.0 million in 2024, then slumped by 160.53% to -$99.0 million in 2025, then fell by 20.2% to -$119.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$119.0 million (Q1 2026), -$99.0 million (Q4 2025), and -$36.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Dentsply Sirona | 2.18 Bn | 1.94 Bn | 493.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.00 Mn |
| Jun 30, 2026 | -11.00 Mn |
| Mar 31, 2026 | -119.00 Mn |
| Mar 31, 2026 | -119.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Mar 31, 2024 | -14.00 Mn |